GEP20022652B - ) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition - Google Patents

) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition

Info

Publication number
GEP20022652B
GEP20022652B GEAP19964221A GEAP1996004221A GEP20022652B GE P20022652 B GEP20022652 B GE P20022652B GE AP19964221 A GEAP19964221 A GE AP19964221A GE AP1996004221 A GEAP1996004221 A GE AP1996004221A GE P20022652 B GEP20022652 B GE P20022652B
Authority
GE
Georgia
Prior art keywords
pharmaceutical composition
disubstiuted
2ones
roduction
imidazolin
Prior art date
Application number
GEAP19964221A
Inventor
Schaefer, (De) Harry
Unverferth, (De) Klaus
Gewald, (De) Karl
Menzer, (De) Manfred
Lankau, (De) Hans-Joachim
Original Assignee
Arzneimittel Werk Dresden Gmbh De
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7771261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20022652(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Arzneimittel Werk Dresden Gmbh De filed Critical Arzneimittel Werk Dresden Gmbh De
Publication of GEP20022652B publication Critical patent/GEP20022652B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Abstract

1. Technical Result Increase in pharmacological data. 2. Essence A compound of the formula (1) wherein R1, R2, X, m and n are provided in the description, method for their production, pharmaceutical composition and use as a medicinal means for treating epilepsy syndromes. 3. Field of Application Chemistry, medicine.
GEAP19964221A 1995-09-05 1996-07-26 ) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition GEP20022652B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19532668A DE19532668A1 (en) 1995-09-05 1995-09-05 Novel, anticonvulsant 1-ar (alk) yl-imidazolin-2-ones which contain a disubstituted amine radical in the 4-position, and process for their preparation

Publications (1)

Publication Number Publication Date
GEP20022652B true GEP20022652B (en) 2002-03-25

Family

ID=7771261

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP19964221A GEP20022652B (en) 1995-09-05 1996-07-26 ) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition

Country Status (32)

Country Link
EP (1) EP0863880B1 (en)
JP (1) JP4030578B2 (en)
CN (1) CN1103762C (en)
AR (1) AR003502A1 (en)
AT (1) ATE254606T1 (en)
AU (1) AU700602B2 (en)
BG (1) BG63917B1 (en)
BR (1) BR9610359A (en)
CA (1) CA2184871C (en)
CZ (1) CZ291839B6 (en)
DE (2) DE19532668A1 (en)
DK (1) DK0863880T3 (en)
EA (1) EA000535B1 (en)
EE (1) EE03562B1 (en)
ES (1) ES2208758T3 (en)
FR (1) FR13C0049I2 (en)
GE (1) GEP20022652B (en)
HK (1) HK1015776A1 (en)
HU (1) HU225956B1 (en)
IL (1) IL123333A (en)
LT (1) LT4482B (en)
LU (1) LU92263I2 (en)
NO (1) NO313829B1 (en)
NZ (1) NZ315624A (en)
PL (1) PL188287B1 (en)
PT (1) PT863880E (en)
SK (1) SK284868B6 (en)
TR (1) TR199800476T1 (en)
TW (1) TW422838B (en)
UA (1) UA46790C2 (en)
WO (1) WO1997009314A1 (en)
ZA (1) ZA967014B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19721580A1 (en) * 1997-05-23 1998-11-26 Dresden Arzneimittel Use of 1-ar (alk) yl-imidazolin-2-one for the treatment of anxiety and tension
US20050070537A1 (en) 2002-10-10 2005-03-31 Chris Rundfeldt Use of dihydroimidazolones for the treatment of dogs
AU2004255414A1 (en) * 2003-07-11 2005-01-20 Boehringer Ingelheim Vetmedica Gmbh Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
EP2093218A1 (en) * 2008-02-22 2009-08-26 Ruggero Fariello Arylalkyl substituted imidazolidinones
KR20140057604A (en) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 Funny current(if) inhibitors for use in a method of treating and preventing heart failure in feline
US9820988B2 (en) 2014-03-24 2017-11-21 Boehringer Ingelheim Vetmedica Gmbh Treatment of epileptic disorders in feline animals
IT202100000782A1 (en) 2021-01-18 2022-07-18 Procos Spa PROCESS FOR THE SYNTHESIS OF IMEPITOIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790380A (en) 1971-10-21 1973-04-20 American Cyanamid Co NEW (P-CHLORO) PHENYL-1 METHYL-3 IMIDAZOLIDINES, 2,4-DISUBSTITUTIONS USEFUL IN PARTICULAR AS ANTIALDOSTERONE DIURETIC AGENTS AND THEIR PREPARATION PROCESS
US4044021A (en) * 1971-10-21 1977-08-23 American Cyanamid Company Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
US3932452A (en) * 1975-02-07 1976-01-13 Morton-Norwich Products, Inc. 1-Arylmethyl-2-imidazolidinones

Also Published As

Publication number Publication date
MX9801742A (en) 1998-08-30
SK284868B6 (en) 2006-01-05
EA000535B1 (en) 1999-10-28
CZ291839B6 (en) 2003-06-18
EA199800271A1 (en) 1998-10-29
BG102287A (en) 1998-09-30
NZ315624A (en) 1998-11-25
DE19532668A1 (en) 1997-03-06
AU6737596A (en) 1997-03-27
PL325413A1 (en) 1998-07-20
CN1103762C (en) 2003-03-26
PT863880E (en) 2004-04-30
DE59610827D1 (en) 2003-12-24
ES2208758T3 (en) 2004-06-16
EP0863880A1 (en) 1998-09-16
LT98047A (en) 1998-10-26
JP4030578B2 (en) 2008-01-09
HK1015776A1 (en) 1999-10-22
BR9610359A (en) 1999-07-06
LT4482B (en) 1999-03-25
PL188287B1 (en) 2005-01-31
CA2184871C (en) 2001-08-21
UA46790C2 (en) 2002-06-17
NO313829B1 (en) 2002-12-09
NO980906L (en) 1998-03-02
AU700602B2 (en) 1999-01-07
HUP9802941A2 (en) 1999-09-28
FR13C0049I1 (en) 2013-09-27
ZA967014B (en) 1997-08-18
ATE254606T1 (en) 2003-12-15
HUP9802941A3 (en) 1999-10-28
FR13C0049I2 (en) 2014-03-28
IL123333A0 (en) 1998-09-24
LU92263I2 (en) 2013-10-07
EE03562B1 (en) 2001-12-17
EP0863880B1 (en) 2003-11-19
BG63917B1 (en) 2003-06-30
CZ66198A3 (en) 1998-07-15
WO1997009314A1 (en) 1997-03-13
HU225956B1 (en) 2008-01-28
SK21698A3 (en) 1998-10-07
CN1200728A (en) 1998-12-02
CA2184871A1 (en) 1997-03-06
TW422838B (en) 2001-02-21
EE9800063A (en) 1998-08-17
TR199800476T1 (en) 1998-06-22
AR003502A1 (en) 1998-08-05
IL123333A (en) 2001-10-31
JPH11512101A (en) 1999-10-19
DK0863880T3 (en) 2004-03-22
NO980906D0 (en) 1998-03-02

Similar Documents

Publication Publication Date Title
MX9606744A (en) Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors.
HUT70536A (en) Arylsulfonamido-substituted hydroxamic acids, process for preparing them and pharmaceutical compositions containing them
UA32543C2 (en) Aryl acetamides having analgetic action, a PROCESS for preparation thereof, pharmaceutical composition and a PROCESS for preparation thereof
AU1462492A (en) Halogen-free, deposit-control fuel additives comprising a hydroxypolyalkene amine, and a process for its production
GR3034412T3 (en) Pro-prodrugs, their production and use.
ZA961074B (en) Chiral Methylphenyloxazolidinones.
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
GEP20002206B (en) Cryptophycins, Method for its Production, Pharmaceutical Composition on Their basis and Use
SG44982A1 (en) Process for the production of 3-aminomethyl-3,5,5-trimethylcyclohexyl amine
GEP20022652B (en) ) Novel 1-AR(Alk)YL-Imidazolin-2Ones Containing a Disubstiuted Amine Radical in the 4th Position, Having an Anti-Convulsive Effect, Method for their roduction and Pharmaceutical Composition
GB9014136D0 (en) Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
ZA944728B (en) alph -amino acid compounds a process for the preparation thereof and pharmaceutical compositions containing them
HUT69372A (en) Diamine salts of clarulanic acid, pharmaceutical compositions containing the same and process for their production
MY114282A (en) Anthracycline derivatives
PL313622A1 (en) Novel urethane containing aminosteroid compounds
ZA925782B (en) N-(isoquinolin-5-ylsulphonyl) azacycloalkanes, process for the preparation thereof and pharmaceutical compositions containing them.
GB9012963D0 (en) Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
ZA95638B (en) Oral administration form having acid active substances and a process for its production
AU5288496A (en) 1-{omega-(3,4-dihydro-2-naphthalenyl)alkyl} cyclic amine derivatives, process for preparing the same, and pharmaceutical composition containing the same
NO302757B1 (en) Non-gelled reaction product containing aminoester groups and their use
PL297491A1 (en) Aryl hydroxyimidazolinylpropionamides
GR3021467T3 (en) New peptide derivates active in the process of cell adhesion, a method to prepare them end pharmaceutical compositions containing them.
GB9014681D0 (en) Tricyclo compounds,a process for their production and a pharmaceutical composition containing the same
ZA934667B (en) N-derivatives of (phenylethyl-Béta-ol) amine, a process for their preparation and pharmaceutical compositions containing the same
MX9802933A (en) Novel amine derivatives of epipodophyllotoxin 2", 3"-dideoxyglycosides, preparation method therefor and use thereof as a drug and for treating cancer.